ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
About 14.2% of INDP shares are held by financial institutions. CITADEL ADVISORS LLC is the top corporate investor, holding 0 shares valued at -. A 0% stake in Indaptus Therapeutics, Inc. is owned by the company. VIVALDI CAPITAL MANAGEMENT LP owns 24K shares valued at $51.60K, which translates its holding of 0.29% of the stake in the company.
Among the INDP insiders holding of 46.48% of the stake in company, NEWMAN MICHAEL JAMES, CSO and Director, holds the largest shares of 1.37M. ANDERSON GLEN R., 10 percent owner, is the second largest INDP insider with ownership of 1.19M shares. MECKLER JEFFREY A, CEO and Director, stands third with possession of 75.37K shares of that stake.